Resolution Program
The resolution program for VIOXX claims in the United States, which was announced on November 9, 2007, is moving forward. Merck & Co., Inc., said on March 3, 2008, that more than 44,000 of the approximately 47,000 individuals who registered eligible injuries have submitted some or all of the materials required for enrollment that could qualify them for an interim payment in the program to resolve state and federal myocardial infarction (MI) and ischemic stroke (IS) claims filed against the Company in the United States.
If all of these eligible submissions are completed in accordance with the Settlement Agreement, this would represent more than 93 percent of the eligible MI and IS claims previously registered with the program.
Currently, Merck is working with the Claims Administrator to examine the registration and enrollment materials that have been received and continue to come in for interim payments. There is a considerable amount of documentation that has to be reviewed before the definitive determination can be made that the thresholds have been met.
Merck is confident that 85% thresholds will be met and exceeded, which will obligate the Company to pay $4.85 billion into the resolution fund.
Claimants who submitted initial enrollment materials by February 29
have until March 31 to complete their enrollment for interim payments.
Interim payments could begin as early as August. Eligible claimants who do
not qualify for interim payments may still enroll in the resolution program
if the claims were filed or tolled prior to Nov. 9, 2007 and their claims
will be counted toward the participation thresholds as provided by the
agreements. The current dea
'/>"/>
| SOURCE Hughes Hubbard & Reed LLP and Herman Herman Katz & Cotlar,LLP
Copyright©2008 PR Newswire. All rights reserved |